Summary
The communication between tumor cells and extracellular matrix (ECM) is responsible for clinically important features of malignant gliomas, such as cerebral invasion and leptomeningeal spread. The synthesis of ECM components, ECM-degrading activities and ECM receptors as well as the interaction between ECM components and their receptors represents the molecular basis for these processes. Recent studies have shown that proteases and integrins, the major group of ECM receptors, may be over-expressed by astrocytic tumor cells. Furthermore, integrins and the hyaluronate receptor CD44 have been found to be involved in adhesion and basement membrane invasion of glioma cells. Critical issues which are poorly understood so far include the ECM composition of the normal human brain and of brain tumors, the function of individual ECM components and receptors in a neuro-oncological context, and the molecular processes mediating the diffuse invasion of glioma cells into the brain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Carbonetto S: The extracellular matrix of the nervous system. Trends Neurosci 76: 382–387, 1984
Kreis T, Vale R (eds): Guidebook to the Extracellular Matrix and Adhesion Proteins. Oxford University Press, Oxford, New York, Toronto, 1993
Venstrom KA, Reichardt LF: Extracellular matrix 2: role of extracellular matrix molecules and their receptors in the nervous system. FASEB J 7: 996–1003, 1993
Letourneau PC, Condic ML, Snow DM: Interactions of developing neurons with the extracellular matrix. J Neurosci 14: 915–928, 1994
Cerda-Nicolas M, Kepes JJ: Gliofibromas (including malignant forms), and gliosarcoma: a comparative study and review of the literature. Acta Neuropathol 85: 349–361, 1993
Higuchi M, Ohnishi T, Arita N, Hiraga S, Hayakawa T: Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol 85: 481–487, 1993
Gladson CL, Cheresh DA: Glioblastoma expression of vitronectin and the αvβ3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88: 1924–1932, 1991
Delpech B, Maingonnat C, Girard N, Chauzy C, Maunoury R, Olivier A, Tayot J, Creissard P: Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma. Eur J Cancer 29A: 1012–1017, 1993
Paulus W, Huettner C, Tonn JC: Collagens, integrins and the mesenchymal drift in glioblastomas: a comparison of biopsy specimens, spheroid and early monolayer cultures. Int J Cancer 58: 841–846, 1994
Peterson DL, Sheridan PJ, Brown WE Jr: Animal models for brain tumors: historical perspectives and future directions. J Neurosurg 80: 865–876, 1994
Thorgeirsson UP, Lindsay CK, Cottam DW, Gomez DE: Tumor invasion, proteolysis, and angiogenesis. J NeuroOncol 18: 89–103, 1994
Rao JS, Steck PA, Mohanam S, Stetler Stevenson WG, Liotta LA, Sawaya R: Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res 53: 2208–2211, 1993
Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nicholson GL, Rao JS: Expression and localization of urokinase-type plasminogen activator in human astrocytomasin vivo. Cancer Res 54: 3656–3661, 1994
McCormick D: Secretion of cathepsin B in human gliomasin vitro. Neuropathol Appl Neurobiol 19: 146–151, 1993
Romanic AM, Madri JA: Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol 4: 145–156, 1994
Albelda SM: Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 68: 4–17, 1993
Paulus W, Baur I, Roggendorf W, Schuppan D: Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol 143: 154–163, 1993
Giese A, Rief MD, Loo MA, Berens ME: Determinants of human astrocytoma migration. Cancer Res 54: 3897–3904, 1994
Merzak A, Koocheckpour S, Pilkington GJ: CD44 mediates human glioma cell adhesion and invasionin vitro. Cancer Res 54: 3988–3992, 1994
Paulus W, Tonn JC: Basement membrane invasion of glioma cells mediated by integrin receptors. J Neurosurg 80: 515–519, 1994
Pilkington GJ: Tumour cell migration in the central nervous system. Brain Pathol 4: 157–166, 1994
Mohanam S, Sawaya R, McCutcheon I, AliOsman F, Boyd D, Rao JS: Modulation ofin vitro invasion of human glio-blastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 53: 4143–4147, 1993
Laws ER Jr, Goldberg WJ, Bernstein JJ: Migration of human malignant astrocytoma cells in the mammalian brain: Scherer revisited. Int J Dev Neurosci 11: 691–697, 1993
Edvardsen K, Pedersen PH, Bjerkvig R, Hermann GG, Zeuthen J, Laerum OD, Walsh FS, Bock E: Transfection of glioma cells with the neural-cell adhesion molecule NCAM: effect on glioma-cell invasion and growthin vivo. Int J Cancer 58: 116–122, 1994
Galileo DS, Majors J, Horwitz AF, Sanes JR: Retrovirally introduced antisense integrin RNA inhibits neuroblast migrationin vivo. Neuron 9: 1117–1131, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paulus, W., Tonn, J.C. Interactions of glioma cells and extracellular matrix. J Neuro-Oncol 24, 87–91 (1995). https://doi.org/10.1007/BF01052664
Issue Date:
DOI: https://doi.org/10.1007/BF01052664